Pfizer Inc. May Make Counter Bid for Ranbaxy Laboratories According to Report

June 13, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MUMBAI (Reuters) - Pfizer Inc may bid for Ranbaxy Laboratories Ltd, countering a $4.6 billion offer by Japan's Daiichi Sankyo Co Ltd (Tokyo:4568.T - News) for the Indian generic drug maker, the Business Standard newspaper said.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions Asia